Medtronic plc — Director's Dealing 2019

Oct 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-10-11

Reporting Person: Surface Carol A (SVP, Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-11	Ordinary Shares	M	7569	$62.76	Acquired	45282	Direct
2019-10-11	Ordinary Shares	M	34189	$78.00	Acquired	79471	Direct
2019-10-11	Ordinary Shares	M	24983	$88.06	Acquired	104454	Direct
2019-10-11	Ordinary Shares	M	17466	$83.97	Acquired	121920	Direct
2019-10-11	Ordinary Shares	F	72848	$107.58	Disposed	49072	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-11	Stock Option (Right to Buy)	$62.76	M	7569	Disposed	2024-07-28	Ordinary Shares (7569)	Direct
2019-10-11	Stock Option (Right to Buy)	$78.00	M	34189	Disposed	2025-08-03	Ordinary Shares (34189)	Direct
2019-10-11	Stock Option (Right to Buy)	$88.06	M	24983	Disposed	2026-08-01	Ordinary Shares (24983)	Direct
2019-10-11	Stock Option (Right to Buy)	$83.97	M	17466	Disposed	2027-07-31	Ordinary Shares (17466)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	546	Indirect
Ordinary Shares	1604	Indirect

Footnotes

F1: Between June 18, 2019 and September 30, 2019, the reporting person acquired 2 shares of MDT common stock under the Medtronic NQ Retirement Plan. The information in this report is based on a statement dated as of October 14, 2019.

F2: Between June 18, 2019 and September 30, 2019, the reporting person acquired 7 shares of MDT common stock under the Medtronic 401(k) Plan. The information in this report is based on a statement dated as of October 14, 2019.

F3: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F5: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

F6: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.